Basics Alto Neuroscience Inc. IPO Date: February 2, 2024 Sector: Healthcare Industry: Biotech Market Cap: $376.21M Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 4.31% Avg Daily Range (30 D): $0.80 | 9.05% Avg Daily Range (90 D): $0.36 | 5.38% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): 2.64M Avg Daily Volume (90 D): .95M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 105 Avg Trade Size (Sh.) (90 D): 106 Institutional Trades Total Inst.Trades: 75 Avg Inst. Trade: $1.58M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.06M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.17M Avg Closing Trade (30 D): $3.88M Avg Closing Trade (90 D): $3.88M Avg Closing Volume: 323.58K     News Oct 7, 2025 @ 10:05 PM ALTO ALERT: Bragar Eagel & Squire, P.C. is Investi... Source: Bragar Eagel & Squire, P.C. Sep 19, 2025 @ 8:49 PM Investors who lost money on Alto Neuroscience, Inc... Source: Levi & Korsinsky, Llp Sep 19, 2025 @ 1:50 PM ANRO DEADLINE TODAY: ROSEN, A HIGHLY RECOGNIZED LA... Source: Rosen Law Firm Sep 18, 2025 @ 8:00 PM ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Sep 18, 2025 @ 3:40 AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates ... Source: James (Josh) Wilson Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.3 $-.52 Diluted EPS $-2.3 $-.52 Revenue $ M $ M $ Gross Profit $ $ $ Net Income / Loss $ -62.26M $ -14.18M $ -17.71M Operating Income / Loss $ -66.31M $ -14.95M $ Cost of Revenue $ $ $ Net Cash Flow $ -43.89M $ $ PE Ratio